# Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma

> **NCT00386906** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 38 (actual)

## Conditions studied

- Eye Disease
- Melanoma

## Interventions

- **PROCEDURE:** Sentinel Lymph Node Mapping and Biopsy

## Key facts

- **NCT ID:** NCT00386906
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05-30
- **Primary completion:** 2023-09-28
- **Final completion:** 2023-09-28
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2025-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00386906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00386906, "Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00386906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*